Download PDF
Journal of Pediatric Neurology 2022; 20(05): 310-318
DOI: 10.1055/s-0042-1751265
Review Article

Cerebrovascular Complications in Pediatric Patients with COVID-19 Infection

Thymur Ali Chaudhry
1   Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
,
Figen Palabiyik
2   Department of Pediatric Radiology, Health Science University, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
,
Sarah J. Moum
3   Department of Medical Imaging, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Since the onset of the coronavirus disease 2019 pandemic, a variety of neurological manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported in patients, of which one of the most concerning is stroke. This review aims to summarize the current literature and evolving understanding of pediatric cerebrovascular complications in the setting of SARS-CoV-2.

Keywords

pediatric stroke - SARS-CoV-2 - cerebrovascular complications


Publication History

Received: 01 June 2022

Accepted: 01 June 2022

Article published online:
02 August 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Mallick AA, Ganesan V, Kirkham FJ. et al. Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol 2014; 13 (01) 35-43
    CrossrefPubMedGoogle Scholar
  • 2 Mittal SO, ThatiGanganna S, Kuhns B, Strbian D, Sundararajan S. Acute ischemic stroke in pediatric patients. Stroke 2015; 46 (02) e32-e34
    CrossrefPubMedGoogle Scholar
  • 3 LaRovere KL, Riggs BJ, Poussaint TY. et al; Overcoming COVID-19 Investigators. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol 2021; 78 (05) 536-547
    CrossrefPubMedGoogle Scholar
  • 4 Ray STJ, Abdel-Mannan O, Sa M. et al; CoroNerve study group. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study. Lancet Child Adolesc Health 2021; 5 (09) 631-641
    CrossrefPubMedGoogle Scholar
  • 5 Tsze DS, Valente JH. Pediatric stroke: a review. Emerg Med Int 2011; 2011: 734506
    PubMedGoogle Scholar
  • 6 Ferriero DM, Fullerton HJ, Bernard TJ. et al; American Heart Association Stroke Council and Council on Cardiovascular and Stroke Nursing. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2019; 50 (03) e51-e96
    Google Scholar
  • 7 Siracusa L, Cascio A, Giordano S. et al. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature. Ital J Pediatr 2021; 47 (01) 123
    CrossrefPubMedGoogle Scholar
  • 8 Beslow LA, Linds AB, Fox CK. et al; International Pediatric Stroke Study Group. Pediatric ischemic stroke: an infrequent complication of SARS-CoV-2. Ann Neurol 2021; 89 (04) 657-665
    CrossrefPubMedGoogle Scholar
  • 9 Oxley TJ, Mocco J, Majidi S. et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020; 382 (20) e60
    CrossrefPubMedGoogle Scholar
  • 10 Mao L, Jin H, Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77 (06) 683-690
    Google Scholar
  • 11 Yaghi S, Ishida K, Torres J. et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke 2020; 51 (07) 2002-2011
    CrossrefPubMedGoogle Scholar
  • 12 Rothstein A, Oldridge O, Schwennesen H, Do D, Cucchiara BL. Acute cerebrovascular events in hospitalized COVID-19 patients. Stroke 2020; 51 (09) e219-e222
    CrossrefPubMedGoogle Scholar
  • 13 Siegler JE, Cardona P, Arenillas JF. et al. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: the SVIN COVID-19 multinational registry. Int J Stroke 2021; 16 (04) 437-447
    CrossrefPubMedGoogle Scholar
  • 14 Centers for Disease Control and Prevention. . (2020). Demographic trends of COVID-19 cases and deaths in the US reported to CDC. COVID data tracker. Accessed 12 March 2022 at: https://covid.cdc.gov/covid-data-tracker/#demographics
    PubMed
  • 15 Mirzaee SMM, Gonçalves FG, Mohammadifard M, Tavakoli SM, Vossough A. Focal cerebral arteriopathy in a pediatric patient with COVID-19. Radiology 2020; 297 (02) E274-E275
    CrossrefPubMedGoogle Scholar
  • 16 Tiwari L, Shekhar S, Bansal A, Kumar S. COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report. Lancet Child Adolesc Health 2021; 5 (01) 88-90
    CrossrefPubMedGoogle Scholar
  • 17 Shen MY, Dugue R, Maldonado-Soto AR, Thakur KT, Zyskind I, Vargas WS. Acute ischemic stroke in a pediatric patient with known exposure to COVID-19 and positive serology. Pediatr Neurol 2021; 116: 39-40
    CrossrefPubMedGoogle Scholar
  • 18 Appavu B, Deng D, Dowling MM. et al. Arteritis and large vessel occlusive strokes in children after COVID-19 infection. Pediatrics 2021; 147 (03) e2020023440
    CrossrefPubMedGoogle Scholar
  • 19 Lehman LL, Beslow LA, Steinlin M, Kossorotoff M, Mackay MT. What will improve pediatric acute stroke care?. Stroke 2019; 50 (02) 249-256
    CrossrefPubMedGoogle Scholar
  • 20 Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology 2003; 61 (02) 189-194
    CrossrefPubMedGoogle Scholar
  • 21 Oleske DM, Cheng X, Jeong A, Arndt TJ. Pediatric acute ischemic stroke by age-group: a systematic review and meta-analysis of published studies and hospitalization records. Neuroepidemiology 2021; 55 (05) 331-341
    CrossrefPubMedGoogle Scholar
  • 22 Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res 2020; 194: 101-115
    CrossrefPubMedGoogle Scholar
  • 23 Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020; 11 (07) 995-998
    CrossrefPubMedGoogle Scholar
  • 24 Miller EH, Namale VS, Kim C. et al. Cerebrospinal analysis in patients with COVID-19. Open Forum Infect Dis 2020; 7 (11) ofaa50
    CrossrefPubMedGoogle Scholar
  • 25 Lewis A, Frontera J, Placantonakis DG. et al. Cerebrospinal fluid in COVID-19: a systematic review of the literature. J Neurol Sci 2021; 421: 117316
    CrossrefPubMedGoogle Scholar
  • 26 Al Saiegh F, Ghosh R, Leibold A. et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry 2020; 91 (08) 846-848
    CrossrefPubMedGoogle Scholar
  • 27 Bikdeli B, Madhavan MV, Jimenez D. et al; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and followup: JACC state-of-the-art review. J Am Coll Cardiol 2020; 75 (23) 2950-2973
    CrossrefPubMedGoogle Scholar
  • 28 O'Loughlin L, Alvarez Toledo N, Budrie L, Waechter R, Rayner J. A systematic review of severe neurological manifestations in pediatric patients with coexisting SARS-CoV-2 infection. Neurol Int 2021; 13 (03) 410-427
    CrossrefPubMedGoogle Scholar
  • 29 Schober ME, Robertson CL, Wainwright MS, Roa JD, Fink EL. COVID-19 and the pediatric nervous system: global collaboration to meet a global need. Neurocrit Care 2021; 35 (02) 283-290
    CrossrefPubMedGoogle Scholar
  • 30 Sharma C, Ganigara M, Galeotti C. et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 2021; 17 (12) 731-748
    CrossrefPubMedGoogle Scholar
  • 31 Feldstein LR, Rose EB, Horwitz SM. et al; Overcoming COVID-19 Investigators, CDC COVID-19 Response Team. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383 (04) 334-346
    CrossrefPubMedGoogle Scholar
  • 32 Haidar MA, Shakkour Z, Reslan MA. et al. SARS-CoV-2 involvement in central nervous system tissue damage. Neural Regen Res 2022; 17 (06) 1228-1239
    CrossrefPubMedGoogle Scholar
  • 33 Matschke J, Lütgehetmann M, Hagel C. et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19 (11) 919-929
    Google Scholar
  • 34 Buzhdygan TP, DeOre BJ, Baldwin-Leclair A. et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis 2020; 146: 105131
    CrossrefPubMedGoogle Scholar
  • 35 Khosravi B, Moradveisi B, Abedini M, Behzadi S, Karimi A. Stroke in a child with SARS-CoV-2 infection: a case report. eNeurologicalSci 2021; 23: 100345
    CrossrefPubMedGoogle Scholar
  • 36 Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis 2020; 50 (03) 499-511
    CrossrefPubMedGoogle Scholar
  • 37 Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell 2020; 183 (01) 16-27.e1
    CrossrefPubMedGoogle Scholar
  • 38 Lou M, Yuan D, Liao S, Tong L, Li J. Potential mechanisms of cerebrovascular diseases in COVID-19 patients. J Neurovirol 2021; 27 (01) 35-51
    CrossrefPubMedGoogle Scholar
  • 39 Lindan CE, Mankad K, Ram D. et al; ASPNR PECOBIG Collaborator Group. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021; 5 (03) 167-177
    CrossrefPubMedGoogle Scholar
  • 40 Ippolito Bastidas H, Márquez-Pérez T, García-Salido A. et al. Cerebral venous sinus thrombosis in a pediatric patient with COVID-19. Neurol Clin Pract 2021; 11 (02) e208-e210
    CrossrefPubMedGoogle Scholar
  • 41 de Marcellus C, Dupic L, Roux CJ. et al. Case report: cerebrovascular events associated with bacterial and SARS-CoV-2 infections in an adolescent. Front Neurol 2021; 12: 606617
    CrossrefPubMedGoogle Scholar
  • 42 Reiff DD, Meyer CG, Marlin B, Mannion ML. New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report. BMC Pediatr 2021; 21 (01) 333
    CrossrefPubMedGoogle Scholar
  • 43 Fireizen Y, Shahriary C, Imperial ME, Randhawa I, Nianiaris N, Ovunc B. Pediatric P-ANCA vasculitis following COVID-19. Pediatr Pulmonol 2021; 56 (10) 3422-3424
    CrossrefPubMedGoogle Scholar
  • 44 Hoskins B, Keeven N, Dang M, Keller E, Nagpal R. A child with COVID-19 and immunoglobulin A vasculitis. Pediatr Ann 2021; 50 (01) e44-e48
    CrossrefPubMedGoogle Scholar
  • 45 Orman G, Desai NK, Kralik SF. et al. Neuroimaging offers low yield in children positive for SARS-CoV-2. AJNR Am J Neuroradiol 2021; 42 (05) 951-954
    CrossrefPubMedGoogle Scholar
  • 46 Wintermark M, Hills NK, DeVeber GA. et al; VIPS Investigators. Clinical and imaging characteristics of arteriopathy subtypes in children with arterial ischemic stroke: results of the VIPS study. AJNR Am J Neuroradiol 2017; 38 (11) 2172-2179
    CrossrefPubMedGoogle Scholar
  • 47 Fullerton HJ, Wintermark M, Hills NK. et al; VIPS Investigators. Risk of recurrent arterial ischemic stroke in childhood: a prospective international study. Stroke 2016; 47 (01) 53-59
    CrossrefPubMedGoogle Scholar
  • 48 Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, Deveber GA, Ganesan V. International Pediatric Stroke Study Group. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol 2011; 69 (01) 130-140
    CrossrefPubMedGoogle Scholar
  • 49 Roach ES, Golomb MR, Adams R. et al; American Heart Association Stroke Council. Council on Cardiovascular Disease in the Young. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008; 39 (09) 2644-2691
    CrossrefPubMedGoogle Scholar
  • 50 Fullerton HJ, Elkind MS, Barkovich AJ. et al. The Vascular effects of Infection in Pediatric Stroke (VIPS) Study. J Child Neurol 2011; 26 (09) 1101-1110
    CrossrefPubMedGoogle Scholar
  • 51 Fullerton HJ, Hills NK, Elkind MS. et al; VIPS Investigators. Infection, vaccination, and childhood arterial ischemic stroke: results of the VIPS study. Neurology 2015; 85 (17) 1459-1466
    CrossrefPubMedGoogle Scholar
  • 52 Wintermark M, Hills NK, deVeber GA. et al; VIPS Investigators. Arteriopathy diagnosis in childhood arterial ischemic stroke: results of the vascular effects of infection in pediatric stroke study. Stroke 2014; 45 (12) 3597-3605
    CrossrefPubMedGoogle Scholar
  • 53 Gulko E, Overby P, Ali S, Mehta H, Al-Mufti F, Gomes W. Vessel wall enhancement and focal cerebral arteriopathy in a pediatric patient with acute infarct and COVID-19 infection. AJNR Am J Neuroradiol 2020; 41 (12) 2348-2350
    CrossrefPubMedGoogle Scholar
  • 54 Foster CH, Vargas AJ, Wells E, Keating RF, Magge SN. Cerebral vasculopathy and strokes in a child with COVID-19 antibodies: illustrative case. J Neurosurg Case Lessons 2021; 2 (03) 21160
    CrossrefPubMedGoogle Scholar
  • 55 Poisson KE, Zygmunt A, Leino D. et al. Lethal pediatric cerebral vasculitis triggered by severe acute respiratory syndrome coronavirus 2. Pediatr Neurol 2022; 127: 1-5
    CrossrefPubMedGoogle Scholar
  • 56 Salik I, Jacoby M. Carotid artery dissection and hemorrhagic stroke in the setting of multisystem inflammatory syndrome in children. Cureus 2021; 13 (03) e13640
    PubMedGoogle Scholar
  • 57 Munoz AC, Tasayco J, Morales W. et al. High incidence of stroke and mortality in pediatric critical care patients with COVID-19 in Peru [published online ahead of print, May 3, 2021]. Pediatr Res DOI: 10.1038/s41390-021-01547-x.
    CrossrefPubMedGoogle Scholar
  • 58 Sánchez-Morales AE, Urrutia-Osorio M, Camacho-Mendoza E. et al. Neurological manifestations temporally associated with SARS-CoV-2 infection in pediatric patients in Mexico. Childs Nerv Syst 2021; 37 (07) 2305-2312
    CrossrefPubMedGoogle Scholar
  • 59 Jillella DV, Philbrook B, Ortolani E. et al. Successful endovascular therapy in COVID-19 associated pediatric ischemic stroke. J Stroke Cerebrovasc Dis 2021; 30 (12) 106152
    CrossrefPubMedGoogle Scholar
  • 60 Al Haboob AA. Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection. Neurosciences (Riyadh) 2021; 26 (03) 295-299
    CrossrefPubMedGoogle Scholar
  • 61 Korkmazer B, Ozogul M, Hikmat E. et al. Posterior reversible encephalopathy syndrome in a pediatric COVID-19 patient. Pediatr Infect Dis J 2021; 40 (06) e240-e242
    CrossrefPubMedGoogle Scholar
  • 62 Basirjafari S, Rafiee M, Shahhosseini B, Mohammadi M, Neshin SAS, Zarei M. Association of pediatric COVID-19 and subarachnoid hemorrhage. J Med Virol 2021; 93 (02) 658-660
    CrossrefPubMedGoogle Scholar
  • 63 Kaushik S, Ahluwalia N, Gangadharan S. et al. ECMO support in SARS-CoV2 multisystem inflammatory syndrome in children in a child. Perfusion 2021; 36 (05) 524-528
    CrossrefPubMedGoogle Scholar
  • 64 Kihira S, Morgenstern PF, Raynes H, Naidich TP, Belani P. Fatal cerebral infarct in a child with COVID-19. Pediatr Radiol 2020; 50 (10) 1479-1480
    CrossrefPubMedGoogle Scholar
  • 65 Schupper AJ, Yaeger KA, Morgenstern PF. Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Childs Nerv Syst 2020; 36 (08) 1579-1580
    CrossrefPubMedGoogle Scholar